These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33527603)

  • 1. Drug survival and safety profile of acitretin monotherapy in patients with psoriasis: A multicenter retrospective study.
    Kara Polat A; Oguz Topal I; Aslan Kayıran M; Koku Aksu AE; Aytekin S; Topaloglu Demir F; Ozkok Akbulut T; Kıvanc Altunay I; Ozkur E; Karadag AS
    Dermatol Ther; 2021 Mar; 34(2):e14834. PubMed ID: 33527603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
    Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile.
    Polat Ekinci A; Bölük KN; Babuna Kobaner G
    Dermatol Ther; 2021 Jan; 34(1):e14704. PubMed ID: 33368934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
    Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
    Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug fever as an adverse effect of acitretin in complicated psoriasis patient.
    Rob F; Fialová J; Brejchová M; Džambová M; Sečníková Z; Zelenková D; Jiráková A; Hercogová J
    Dermatol Ther; 2015; 28(6):366-8. PubMed ID: 26133643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acitretin improves psoriasis in a dose-dependent fashion.
    Goldfarb MT; Ellis CN; Gupta AK; Tincoff T; Hamilton TA; Voorhees JJ
    J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):655-62. PubMed ID: 2967310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing acitretin use in patients with plaque psoriasis.
    Chiricozzi A; Panduri S; Dini V; Tonini A; Gualtieri B; Romanelli M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.
    Pang ML; Murase JE; Koo J
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):953-64. PubMed ID: 18624682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acitretin.
    Ortiz NE; Nijhawan RI; Weinberg JM
    Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.
    Borghi A; Corazza M; Bertoldi AM; Caroppo F; Virgili A
    Acta Derm Venereol; 2015 Mar; 95(3):332-6. PubMed ID: 24978351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study.
    Chularojanamontri L; Silpa-Archa N; Wongpraparut C; Limphoka P
    Int J Dermatol; 2019 May; 58(5):593-599. PubMed ID: 30548592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side-effect profile of acitretin therapy in psoriasis.
    Gupta AK; Goldfarb MT; Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1989 Jun; 20(6):1088-93. PubMed ID: 2526824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis.
    Hu J; Balkrishnan R; Camacho F; Lang W; Pearce DJ; Fleischer AB; Feldman SR
    J Cutan Med Surg; 2004; 8(6):411-4. PubMed ID: 15988549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of acitretin, a systemic retinoid for the treatment of psoriasis.
    Lee CS; Koo J
    Expert Opin Pharmacother; 2005 Aug; 6(10):1725-34. PubMed ID: 16086658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
    Smith EC; Riddle C; Menter MA; Lebwohl M
    Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of palmoplantar pustulosis with isotretinoin.
    Wilken R; Sharma A; Patel F; Maverakis E
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy.
    Rim JH; Park JY; Choe YB; Youn JI
    Am J Clin Dermatol; 2003; 4(7):507-10. PubMed ID: 12814339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.